Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Odiglim-M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Zinnia Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Odiglim-M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature cessation can lead to elevated glucose, risking complications like kidney impairment, vision loss, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.

Primary Ingredients of Odiglim-M 1mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Odiglim-M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Odiglim-M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Odiglim-M 1mg/500mg tablets with a meal.

Common Side effects of Odiglim-M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Odiglim-M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. It's recommended to take the Odiglim-M 1mg/500mg Tablet with a meal.

How Odiglim-M 1mg/500mg Tablet works:

Odiglim-M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Odiglim-M 1mg/500mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Odiglim-M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Odiglim-M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Odiglim-M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Odiglim-M 1mg/500mg tablets are contraindicated in patients with severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Odiglim-M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Odiglim-M 1mg/500mg Tablet :

Should you forget to take your Odiglim-M 1mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Odiglim-M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Odiglim-M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Odiglim-M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Odiglim-M 1mg/500mg Tablets and seek immediate medical attention.
Odiglim-M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Odiglim-M 1mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Odiglim-M 1mg/500mg tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, yearly supplemental Vitamin B12 is recommended by some researchers.
Odiglim-M 1mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Odiglim-M 1mg/500mg Tablet and alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Odiglim-M 1mg/500mg Table...
25
MRP 29
13% off